NCT03020589View on ClinicalTrials.gov

Study of Pharmacogenomic-Guided Tacrolimus Dosing and Monitoring in Kidney Transplant Recipients

PHASE4CompletedINTERVENTIONAL
Enrollment

97

Participants

Timeline

Start Date

February 6, 2017

Primary Completion Date

July 31, 2021

Study Completion Date

June 28, 2022

Conditions
Renal Transplant
Interventions
DRUG

Tacrolimus

See description in arm/group sections

Trial Locations (1)

27514

Univeristy of North Carolina, Chapel Hill

All Listed Sponsors
lead

University of North Carolina, Chapel Hill

OTHER

NCT03020589 - Study of Pharmacogenomic-Guided Tacrolimus Dosing and Monitoring in Kidney Transplant Recipients | Biotech Hunter | Biotech Hunter